Article
Comprehensive benchmarking of SNV callers for highly admixed tumor data.
PloS one - 1 Jan 2017
Bohnert Regina, Vivas Sonia, Jansen Gunther
Abstract excerpt
Precision medicine attempts to individualize cancer therapy by matching tumor-specific genetic changes with effective targeted therapies. A crucial first step in this process is the reliable identification of cancer-relevant variants, which is considerably complicated by the impurity and heterogeneity of clinical tumor samples. We compared the impact of admixture of non-cancerous cells and low somatic allele...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
